Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, Pharmaceuticals, and Research/Analytical – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced December 2014-January 2015.
Providing it with an entry into the US market, UK-based DNA Electronics Ltd. (DNAe) paid $24mm in cash for nanoMR Inc., a private developer of systems that rapidly isolate cells for further analysis. (Jan.)
Founded in 2007 around technology licensed from the University of New Mexico and ABQMR, nanoMR has developed a system...